Uloric®

Uloric®, a medication prescribed for the management of chronic gout, has been linked to an increased risk of heart attack and/or stroke. Uloric lawsuits claim the manufacturer of Uloric failed to warn users of the increased risk of these side effects. If you suffered cardiovascular problems while taking Uloric for at least 30 days, you may have a legal claim and be entitled to compensation.

Gout is a form of arthritis, often in the feet and toes, which results from elevated uric acid levels in the bloodstream. Uloric (Febuxostat) is a xanthine oxidase inhibitor prescribed for the management of chronic hyperuricemia (excess uric acid) in adult patients with gout. Uloric is manufactured by Takeda Pharmaceuticals and originally received FDA approval on February 13, 2009.

In 2017, the FDA mandated Takeda Pharmaceuticals to conduct a safety clinical trial for Uloric. The findings of this safety trial showed an increased risk of heart-related deaths and deaths from all causes compared to the alternative gout medication, allopurinol. Similarly, a 2018 safety study published in the New England Journal of Medicine showed that, compared to the alternative generic gout medication Allopurinol, Uloric was linked to a statistically significant increase in deaths due to heart attack and stroke. 

NO COST WITHOUT RECOVERY

If you or a loved one is the victim of Uloric, contact our law firm to find out your rights. The Robichaux Law Firm, LLC has over 40 years of experience helping victims of defective products receive financial compensation.

Our firm does not charge a fee for initial consultations. We work on a contingency fee, and there is no charge to our clients if we are unable to recover money for you.

 

TALK TO US TODAY

We are here for you. Give us a call at (504) 286-2022 or toll free at 1-800-404-9281 to speak to one of our trusted defective product attorneys in New Orleans, LA.

 
Our law firm is currently accepting Uloric cases. If you believe you have a valid Uloric legal claim, contact our office for a free case evaluation.